BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 2334938)

  • 41. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C; Gescher A; Bradshaw TD; Pettit GR
    Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
    Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
    Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of protein kinase C-alpha and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells.
    Goodall AR; Turner NA; Walker JH; Ball SG; Vaughan PF
    J Neurochem; 1997 Jan; 68(1):392-401. PubMed ID: 8978751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells.
    Ramsdell JS; Pettit GR; Tashjian AH
    J Biol Chem; 1986 Dec; 261(36):17073-80. PubMed ID: 3465727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters.
    Goode NT; Moore JP; Hart IR
    Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
    Nutt JE; Harris AL; Lunec J
    Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein kinase C activation and down-regulation in relation to phorbol ester-induced differentiation of SH-SY5Y human neuroblastoma cells.
    Heikkilä JE; Akerlind G; Akerman KE
    J Cell Physiol; 1989 Sep; 140(3):593-600. PubMed ID: 2550478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
    Boorne AJ; Donnelly N; Schrey MP
    Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells.
    Fagerström S; Påhlman S; Gestblom C; Nånberg E
    Cell Growth Differ; 1996 Jun; 7(6):775-85. PubMed ID: 8780891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.
    Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit GR; Herald CL; Marks F
    Carcinogenesis; 1988 Apr; 9(4):555-62. PubMed ID: 2451575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of the jun-B gene during induction of monocytic differentiation.
    Datta R; Sherman ML; Stone RM; Kufe D
    Cell Growth Differ; 1991 Jan; 2(1):43-9. PubMed ID: 2007095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.
    Smith JB; Smith L; Pettit GR
    Biochem Biophys Res Commun; 1985 Nov; 132(3):939-45. PubMed ID: 3907633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition.
    Carey JO; Posekany KJ; deVente JE; Pettit GR; Ways DK
    Blood; 1996 May; 87(10):4316-24. PubMed ID: 8639791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of gene expression in the acute promyelocytic leukemia cell line NB4.
    Hu ZB; Ma W; Uphoff CC; Lanotte M; Drexler HG
    Leukemia; 1993 Nov; 7(11):1817-23. PubMed ID: 7901456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
    Steube KG; Grunicke D; Drexler HG
    Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decline in c-myc mRNA expression but not the induction of c-fos mRNA expression is associated with differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM; Heikkilä JE; Akerman KE
    Exp Cell Res; 1988 Nov; 179(1):10-7. PubMed ID: 3169138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
    Steube KG; Grunicke D; Quentmeier H; Drexler HG
    Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
    Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM
    Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein.
    Cioffi CL; Fisher SK
    J Neurochem; 1990 May; 54(5):1725-34. PubMed ID: 2157816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells.
    Dale IL; Gescher A
    Int J Cancer; 1989 Jan; 43(1):158-63. PubMed ID: 2910827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.